13F filer · CIK 895421 ↗
Morgan Stanley
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$880.47B
+20% on the quarter before
Positions
7,888
339 new · 454 sold out
Top 10
14.5%
of the value
Est. gain
+$47.56B
on stocks held all quarter
Est. return
+6.7%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Morgan Stanley's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 23% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$3.51BAdded · 3.3% → 3.3%+14,652,150 shares
- Apple~$3.37BAdded · 3.4% → 3.1%+25,926,552 shares
- Alphabet~$1.74BAdded · 0.7% → 0.7%+19,612,974 shares
- Amazon~$1.74BAdded · 1.9% → 1.3%+20,669,566 shares
- Eli Lilly~$1.35BAdded · 0.4% → 0.5%+3,691,436 shares
- Visa Inc.~$1.22BAdded · 1.1% → 1.2%+5,864,340 shares
- Jpmorgan Chase & Co~$1.08BAdded · 0.7% → 0.9%+8,088,433 shares
- Berkshire Hathaway Inc Del~$1.00BAdded · 0.7% → 0.8%+3,251,658 shares
- Unitedhealth Group Inc~$1.00BAdded · 0.9% → 0.9%+1,893,192 shares
- Tjx Cos Inc New~$992.5MAdded · 0.1% → 0.2%+12,468,119 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF Tr~$2.79BCut · 1.6% → 1.1%−7,292,063 shares
- Ishares Tr~$1.75BCut · 0.5% → 0.3%−10,021,891 shares
- Ishares Tr~$701.8MCut · 0.2% → 0.1%−9,531,392 shares
- Pimco ETF Tr~$611.8MCut · 0.2% → 0.1%−6,201,542 shares
- Select Sector SPDR Tr~$575.5MCut · 0.2% → 0.2%−6,579,909 shares
- Cigna Corp New~$474.4MCut · 0.2% → 0.1%−1,431,705 shares
- Ishares Tr~$429.3MCut · 0.1% → 0.0%−15,169,119 shares
- Ishares Tr~$426.5MCut · 0.7% → 0.5%−1,109,963 shares
- Brookfield Asset Mgmt Inc~$379.0MSold out · 0.1% → 0.0%−9,268,375 shares
- Twitter Inc~$347.9MSold out · 0.0% → 0.0%−7,936,772 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +14% · price +3.0% | 3.3% | $28.64B | +$725.0M | ||||||||
| AppleCOM · shares +14% · price −6.0% | 3.1% | $27.11B | −$1.51B | ||||||||
| AmazonCOM · shares +17% · price −25.7% | 1.3% | $11.85B | −$3.49B | ||||||||
| Visa Inc.COM CL A · shares +13% · price +16.9% | 1.2% | $10.62B | +$1.36B | ||||||||
| SPDR S&P 500 ETF TrTR UNIT · shares −22% · price +7.1% | 1.1% | $10.03B | +$662.1M | ||||||||
| AlphabetCAP STK CL A · shares +6.8% · price −7.8% | 1.0% | $8.86B | −$698.0M | ||||||||
| Unitedhealth Group IncCOM · shares +14% · price +5.0% | 0.94% | $8.29B | +$345.5M | ||||||||
| Jpmorgan Chase & CoCOM · shares +16% · price +28.3% | 0.90% | $7.92B | +$1.51B | ||||||||
| Johnson & JohnsonCOM · shares +12% · price +8.1% | 0.85% | $7.46B | +$501.1M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +17% · price +15.7% | 0.78% | $6.88B | +$797.1M | ||||||||
| Procter And Gamble CoCOM · shares +13% · price +20.0% | 0.76% | $6.72B | +$996.2M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +18% · price +8.6% | 0.73% | $6.46B | +$433.5M | ||||||||
| AlphabetCAP STK CL C · shares +38% · price −7.7% | 0.72% | $6.37B | −$387.1M | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares −0.6% · price +7.0% | 0.70% | $6.19B | +$406.2M | ||||||||
| Home Depot IncCOM · shares +10.0% · price +14.5% | 0.67% | $5.92B | +$680.2M | ||||||||
| Chevron Corp NewCOM · shares +13% · price +24.9% | 0.67% | $5.91B | +$1.05B | ||||||||
| Exxon Mobil CorpCOM · shares +12% · price +26.3% | 0.66% | $5.79B | +$1.08B | ||||||||
| MastercardCL A · shares +18% · price +22.3% | 0.63% | $5.51B | +$853.1M | ||||||||
| Danaher CorporationCOM · shares +18% · price +2.8% | 0.60% | $5.28B | +$120.5M | ||||||||
| Abbvie IncCOM · shares +18% · price +20.4% | 0.58% | $5.10B | +$733.9M | ||||||||
| Coca Cola CoCOM · shares +16% · price +13.5% | 0.57% | $5.03B | +$519.0M | ||||||||
| Pepsico IncCOM · shares +21% · price +10.7% | 0.55% | $4.83B | +$384.4M | ||||||||
| Ishares TrRUS 1000 GRW ETF · shares +6.2% · price +1.8% | 0.54% | $4.73B | +$79.9M | ||||||||
| Ishares TrCORE S&P500 ETF · shares −8.3% · price +7.1% | 0.54% | $4.71B | +$313.6M | ||||||||
| Ishares TrRUS 1000 VAL ETF · shares +0.9% · price +11.5% | 0.53% | $4.66B | +$476.6M | ||||||||
| Total · 7,888 positions | 100% | $880.47B | +$47.56B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 7,091 stocks held throughout, up $47.56B (+6.7%).
- Jpmorgan Chase & Co+$1.51B+28%
- Visa Inc.+$1.36B+17%
- Exxon Mobil Corp+$1.08B+26%
- Chevron Corp New+$1.05B+25%
- Procter And Gamble Co+$996.2M+20%
- The Trade Desk−$521.1M−25%
- Alphabet−$698.0M−8%
- Apple−$1.51B−6%
- Tesla−$2.86B−54%
- Amazon−$3.49B−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 40 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $1.89T+14% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.66T−1% | SEC ↗ |
| Q4 2025 | May 27, 2026 (amended) | $1.67T+1% | SEC ↗ |
| Q3 2025 | May 27, 2026 (amended) | $1.65T+8% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $1.54T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.40T−2% | SEC ↗ |
| Q4 2024 | May 15, 2025 (amended) | $1.43T+3% | SEC ↗ |
| Q3 2024 | May 14, 2025 (amended) | $1.38T+7% | SEC ↗ |
| Q2 2024 | May 14, 2025 (amended) | $1.29T−65% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $3.74T+65% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 (amended) | $2.27T+131% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $983.41B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.01T+9% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $932.64B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $880.47B+20% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $733.72B−5% | SEC ↗ |
| Q2 2022 | Oct 27, 2022 (amended) | $770.42B+4% | SEC ↗ |
| Q1 2022 | Oct 27, 2022 (amended) | $741.46B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $809.87B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $742.48B−2% | SEC ↗ |
| Q2 2021 | Aug 23, 2021 (amended) | $758.13B+11% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $680.76B+5% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $647.47B+25% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $517.01B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $451.78B+23% | SEC ↗ |
| Q1 2020 | May 26, 2020 (amended) | $367.99B−14% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $430.00B+14% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $377.76B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $375.74B+6% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $353.27B+6% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $334.17B−16% | SEC ↗ |
| Q3 2018 | Apr 23, 2019 (amended) | $399.53B+8% | SEC ↗ |
| Q2 2018 | Apr 23, 2019 (amended) | $370.13B+3% | SEC ↗ |
| Q1 2018 | Apr 23, 2019 (amended) | $360.30B−1% | SEC ↗ |
| Q4 2017 | Apr 23, 2019 (amended) | $365.35B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $333.86B+1% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $331.01B−49% | SEC ↗ |
| Q1 2017 | May 12, 2017 (amended) | $651.13B+7% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 (amended) | $611.12B+109% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $292.79B+6% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $276.85B+7% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $259.85B | SEC ↗ |